Cargando…
Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model
Striated preferentially expressed protein kinase (SPEG), a myosin light chain kinase, is mutated in centronuclear myopathy (CNM) and/or dilated cardiomyopathy. No precise therapies are available for this disorder, and gene replacement therapy is not a feasible option due to the large size of SPEG. W...
Autores principales: | Li, Qifei, Lin, Jasmine, Widrick, Jeffrey J., Luo, Shiyu, Li, Gu, Zhang, Yuanfan, Laporte, Jocelyn, Perrella, Mark A., Liu, Xiaoli, Agrawal, Pankaj B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462472/ https://www.ncbi.nlm.nih.gov/pubmed/35763354 http://dx.doi.org/10.1172/jci.insight.157336 |
Ejemplares similares
-
Striated Preferentially Expressed Protein Kinase (SPEG) in Muscle Development, Function, and Disease
por: Luo, Shiyu, et al.
Publicado: (2021) -
BIN1 modulation in vivo rescues dynamin-related myopathy
por: Lionello, Valentina Maria, et al.
Publicado: (2022) -
Novel SPEG variant cause centronuclear myopathy in China
por: Tang, Jia, et al.
Publicado: (2019) -
Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy
por: Espinosa, Karla G., et al.
Publicado: (2022) -
Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin
por: Muñoz, Xènia Massana, et al.
Publicado: (2020)